WANDA BEARING
920002
CG MED EQUIP.
838810
SUZHOUBEARING
430418
4
COCYBER
835207
5
Guangdong Create Century Intelligent Equipment Group Corporation
300083
US Stock MarketDetailed Quotes
CADL Candel Therapeutics
- 8.385
- -2.575-23.49%
Close Feb 25 16:00 ET
- 8.410
- +0.025+0.30%
Pre 06:07 ET
372.93MMarket Cap-4.85P/E (TTM)
11.650High8.030Low3.53MVolume11.555Open10.960Pre Close32.47MTurnover10.74%Turnover RatioLossP/E (Static)44.48MShares14.60052wk High-24.45P/B275.85MFloat Cap1.34052wk Low--Dividend TTM32.90MShs Float14.780Historical High--Div YieldTTM33.03%Amplitude0.660Historical Low9.191Avg Price1Lot Size
About Candel Therapeutics Company
Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.
Company Profile
SymbolCADL
Company NameCandel Therapeutics
Listing DateJul 27, 2021
Issue Price8.00
Founded2002
CEODr. Paul Peter Tak, M.D.,PhD
MarketNASDAQ
Employees42
Fiscal Year Ends12-31
Address117 Kendrick Street,Suite 450
CityNeedham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02494
Phone1-617-916-5445
Websitehttp://www.candeltx.com
Company Executives
- Name
- Position
- Salary
- Dr. Paul Peter Tak, M.D.,PhD
- President, Chief Executive Officer and Director
- 1.48M
- Charles Schoch
- Interim Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Francesca Barone, M.D.,PhD
- Chief Scienctific Officer
- 706.88K
- Dr. William Garrett Nichols, M.A.,M.D.
- Chief Medical Officer
- --
- Seshu Tyagarajan, PhD,R.A.C.
- Chief Technical and Development Officer
- --
- Paul B. Manning
- Chairman of the Board
- 83.19K
- Dr. Estuardo Aguilar-Cordova, M.D.,PhD
- Director
- 48.19K
- Joseph C. Papa
- Independent Director
- 58.19K
- Christopher Martell
- Independent Director
- 67.19K
- Dr. Gary J. Nabel, M.D.,PhD
- Independent Director
- 52.19K
- Dr. Edward J. Benz, Jr,M.D.
- Independent Director
- 56.19K
- Dr. Nicoletta Loggia, PhD,R.Ph.
- Independent Director
- 52.76K
- Dr. Diem Nguyen, M.B.A.,PhD
- Independent Director
- 60.69K
- Renee M. Gaeta
- Independent Director
- 55.69K
Trending Stocks
Discussing
Widespread uptick! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets.
Moomoo News Global
Feb 24 22:30
Chinese Stocks' Wild Rally Hits Pause? Wall Street Still Bets Big on Favorites